How long should you stay on Zepbound?

Most people regain a significant portion of lost weight after stopping Zepbound. Clinical trial data (SURMOUNT-4) showed participants who discontinued tirzepatide after an initial treatment phase regained roughly two-thirds of their lost weight within about a year. This reflects the chronic nature of obesity — pharmacotherapy manages the condition while you take it, similar to how blood pressure medication controls hypertension only while being taken. Talk to your prescriber before stopping.

There is no FDA-defined maximum duration — Zepbound is approved for chronic weight management, meaning it is intended for ongoing use rather than a fixed course. Long-term safety data from clinical trials extends through about two to three years of treatment. Whether you continue depends on your response, tolerability, and individual health circumstances as judged by your prescriber, rather than a built-in stop date.

Stopping and restarting is possible, but clinical evidence suggests weight regain during the break is common. If you need to pause Zepbound — for cost, supply issues, or a medical reason — talk to your prescriber about the plan. Restarting may require beginning at a lower dose and re-titrating, and the process for regaining lost weight can take time. Do not restart without medical guidance, especially if your health situation has changed.

Your prescriber will typically evaluate response at regular intervals — generally looking for meaningful weight loss after the initial titration period. FDA-approved prescribing guidance suggests reassessing if response is insufficient after a period of treatment at the full dose. If you are not seeing adequate results, your prescriber may adjust the approach or discuss alternatives.

The longest Zepbound clinical trial data available covers approximately two to three years of treatment, and no new major safety concerns emerged over that period beyond what was observed in shorter trials. Long-term safety monitoring is ongoing. As with any medication for chronic use, regular follow-up with your prescriber — including periodic review of thyroid function and other relevant labs — is important.

Zepbound (tirzepatide) has an elimination half-life of about five days, so a single dose takes roughly 25 to 30 days (about five half-lives) to fully clear the body. Because it is injected weekly, blood levels build up with repeated doses and do not drop to zero between injections during ongoing treatment. After your last dose, residual tirzepatide can still be detectable in your system for roughly a month.

Zepbound is FDA-approved and studied as a once-weekly injection; spacing doses out to every 14 days is not the approved regimen and has not been studied for maintaining the same effect. Stretching the interval on your own can reduce effectiveness and is not recommended without your prescriber's guidance. If cost or supply is the reason, talk to your prescriber about documented alternatives.

Microdosing — taking doses smaller than the approved starting dose — is an off-label practice that has not been studied in Zepbound's clinical trials, so its safety and effectiveness are not established. The approved titration schedule already starts at a low dose (2.5 mg) specifically to minimize side effects before increasing. Any deviation from the approved dosing schedule should be discussed with and supervised by your prescriber.

The maximum approved Zepbound dose is 15 mg weekly; exceeding it increases the risk and severity of side effects such as nausea, vomiting, and diarrhea without established additional benefit, since clinical trials did not test higher doses. Taking more than prescribed is not recommended. If your current dose feels insufficient, discuss adjusting it with your prescriber rather than self-increasing.

There is no required time of day — Zepbound can be injected at any time, with or without food, as long as it is done about once a week. Many people pick a time that is easy to remember consistently, such as the same day and time each week, since the main requirement is a steady weekly schedule rather than a specific hour.